WO2007091801A1 - A sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem - Google Patents
A sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem Download PDFInfo
- Publication number
- WO2007091801A1 WO2007091801A1 PCT/KR2007/000544 KR2007000544W WO2007091801A1 WO 2007091801 A1 WO2007091801 A1 WO 2007091801A1 KR 2007000544 W KR2007000544 W KR 2007000544W WO 2007091801 A1 WO2007091801 A1 WO 2007091801A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cellulose
- skin
- bio
- sheet
- sheet device
- Prior art date
Links
- 229920002678 cellulose Polymers 0.000 title claims abstract description 37
- 239000001913 cellulose Substances 0.000 title claims abstract description 37
- 230000037380 skin damage Effects 0.000 title claims abstract description 22
- 230000005808 skin problem Effects 0.000 title claims abstract description 18
- 229920001340 Microbial cellulose Polymers 0.000 claims description 27
- 239000003814 drug Substances 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 14
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 claims description 6
- -1 sulfonamide acetate Chemical class 0.000 claims description 4
- 229940099259 vaseline Drugs 0.000 claims description 4
- TYMRLRRVMHJFTF-UHFFFAOYSA-N Mafenide Chemical compound NCC1=CC=C(S(N)(=O)=O)C=C1 TYMRLRRVMHJFTF-UHFFFAOYSA-N 0.000 claims description 3
- 229940022663 acetate Drugs 0.000 claims description 3
- 229940099261 silvadene Drugs 0.000 claims description 3
- 229960003600 silver sulfadiazine Drugs 0.000 claims description 3
- 229940091629 sulfamylon Drugs 0.000 claims description 3
- 229940124530 sulfonamide Drugs 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 10
- 210000000416 exudates and transudate Anatomy 0.000 abstract description 5
- 206010040880 Skin irritation Diseases 0.000 abstract description 3
- 230000036556 skin irritation Effects 0.000 abstract description 3
- 231100000475 skin irritation Toxicity 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 24
- 206010052428 Wound Diseases 0.000 description 19
- 208000027418 Wounds and injury Diseases 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 206010016807 Fluid retention Diseases 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 235000015197 apple juice Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000589220 Acetobacter Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000012092 media component Substances 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 239000008104 plant cellulose Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 235000002837 Acetobacter xylinum Nutrition 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 241001136169 Komagataeibacter xylinus Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000012891 Ringer solution Substances 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000009975 flexible effect Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000020334 white tea Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Definitions
- the present invention relates to a natural sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem.
- a sheet device herein which comprises microbial cellulose and optionally further comprises pure or mixed active drug, may effectively absorb the exudates, thus being useful as a sheet device that may effectively alleviate skin damage such as a wound and a burn, etc. and relieve skin problem without skin irritation.
- a sheet device such as a sheet, a patch and a mask pack
- Various sheets, patches and mask packs for skin care is commercially available, and a sheet device useful in delivering skin care activator such as vitamin activator, treatment activator and moisture supplier is also known and used in medical treatment for the transdermal delivery of medicines.
- a cosmetic mask pack is prepared by infiltrating face lotion in non-woven fabric, which contains plant cellulose as a main ingredient, or by coating collagen on non-woven fabric.
- non-woven fabric has a drawback of low water retentive property.
- some sheet devices easily become damp and sticky because they do not form solid gel structure, thus being difficult to handle and apply to the skin.
- Other patches also show too strong adhesion during the attachment or detachment, thus giving tight and uncomfortable feeling, and do not make active drug effectively released and penetrated.
- some sheet devices can not be conformed to the curvature of skin due to the dry and non-flexible property.
- Microbial cellulose is a polymer produced through cultivating strains in various bacteria, particularly Acetobacter genus, and obtained in the form of semi-transparent pellicle existing in culture medium under the stationary cultivation [GB patent No. 2131701]. Although it is linked by ⁇ -1,4 glucosidic bonds like cellulose, microbial cellulose has significant industrial utility in that the fiber width is about 0.04-0. l ⁇ m, i.e. about 150 times smaller than that of cellulose (20-50 ⁇ m) and that it has three- dimensional network structure.
- a microbial cellulose gel plate may create humid atmosphere and decrease the dead space in the wounds (Wound Hydration), (ii) may protect the wounds from exterior pollution source and bacteria, and may create and maintain the optimum humid atmosphere for assisting natural recovery, (iii) may manage excess exudates (Exudate Management), and (iv) is safe and non-noxious.
- the present inventors perceived that a microbial cellulose gel plate has very similar properties to pulp, while being superior in water-absorptive and water-retentive property owing to the three-dimensional network structure, which is denser than that of pulp.
- bio-cellulose may be prepared by post-treating microbial cellulose produced through cultivating strains in Acetobacter genus, while maintaining the original gel phase, followed by compression and removal of moisture, and that thus prepared bio-cellulose may maintain the characteristic three-dimensional network structure and contain a wound-treating agent and various water retention agents, thus being useful as a material for manufacturing a sheet or patch for effectively alleviating skin damage or a mask pack for relieving skin problem. Disclosure of Invention Technical Problem
- the present invention aims to provide a sheet device useful in alleviating skin damage due to a burn and a wound and relieving skin problem without irritation.
- the present invention provides a sheet device comprising bio-cellulose.
- a sheet device herein may be prepared into a sheet, a patch for treating or alleviating skin damage due to a burn and a mask pack for relieving skin problem.
- Bio-cellulose herein may comprise microbial cellulose, an active drug and moisture.
- bio-cellulose herein may comprise 1-50 wt% of microbial cellulose, 1-10 wt% of an active drug and 40-98 wt% of moisture, preferably 3-10 wt% of microbial cellulose, 1-5 wt% of an active drug and 70-96 wt% of moisture.
- An active drug herein may be selected among sulfonamide acetate, sulfamylon, silver sulfadiazine, silvadene, Vaseline and a mixture thereof.
- a sheet device herein may further comprise a water-retention agent in the amount of 15.0-20.0 wt% relative to the total weight of the sheet device.
- a water-retention agent herein may be selected among glycerin, propylene glycol, butylene glycol, polyethylene glycol, sorbitol, maltitol, polyhydric alcohol, hyaluronic acid, amino acid, natto gum and sodium lactate.
- a sheet device may also comprise a growth factor (e.g.
- TGF-,TGF-, TNF-, PDGF, bFGF, GM-CSF, IL-I, IL-6, IL-8 and fibronectin) to promote the treatment of a wound by accelerating the proliferation and movement of keratinocyte and fibroblast.
- a combinational secretion of various factors stimulates dermal fibroblast and promotes the generation of collagen, thus creating an atmosphere where the re-epitheliatization of wounds may happen from periwound skin and skin appendages.
- a sheet device herein may comprise a sequestering agent (or a chelating agent) such as EDTA (ethylenediamine tetraacetic acid), citric acid and NTA (nitrilotriacetic acid) in the amount of 0.01-0.5 wt% relative to the weight of total weight of the sheet device.
- a sequestering agent such as EDTA (ethylenediamine tetraacetic acid), citric acid and NTA (nitrilotriacetic acid) in the amount of 0.01-0.5 wt% relative to the weight of total weight of the sheet device.
- a sheet device herein may further comprise an antioxidant such as WHITE TEA, tocopherol, gallic acids, BHT and BHA in the amount of 0.5-1.0 wt% to inhibit the oxidation; a soothing agent such as DPG (dipotassium glycyrrhizate) in the amount of 0.01-0.5 wt%; a solubilizing agent such as POE hydrogenated castor oil and POE oleyl alcohol ether in the amount of 0.01-0.1 wt%; and a saponifying agent such as triethanolamine in the amount of 0.01-0.2wt%.
- the aforementioned ingredients may be incorporated into the sheet device in combination with deionized water, and the amounts above are relative to the total weight of the sheet device.
- a sheet device comprising bio-cellulose herein has a very dense structure and shows superiority in skin adhesion and water retention.
- a sheet device herein When applied to the damaged skin of men or animals, a sheet device herein has been ascertained as effective in rapidly alleviating skin damage, and also as effective in safely relieving skin problem without irritation.
- a skin device herein may be useful for the purpose of alleviating skin damage and relieving skin problem.
- Figure 1 is a photograph, which compares change of the skin condition after applying bio-cellulose sheet of the present invention ⁇ series (b) ⁇ with that after applying commercially available gauze ⁇ series (a) ⁇ to a burn-induced hairless mouse.
- Figure 2 is a SEM photograph, which compares between cellulose of the present invention ⁇ photograph (a) ⁇ and plant cellulose ⁇ photograph (b) ⁇ . Best Mode for Carrying Out the Invention
- Bio-cellulose of the present invention may be prepared by adding fructose and moisture in a microbial cellulose as described below.
- a process for preparing bio-cellulose from a microbial cellulose comprises the steps of:
- the present invention provides a thus prepared sheet device comprising bio- cellulose as an active ingredient, which is useful in alleviating skin damage due to a wound and a burn and relieving skin problem.
- the followings have been ascertained with regard to the sheet device: (i) it has a very dense structure by SEM analysis, (ii) it shows superiority in skin adhesion and water retention, (iii) when applied to the damaged skin of human or animal, it is effective in rapidly alleviating skin damage and safely relieving skin problem without irritation.
- the present invention has been completed based on the aforementioned advantages of a sheet device herein. Mode for the Invention [23] The present invention is described more specifically by the following Examples and
- Bio-cellulose of the present invention may be prepared by adding fructose and moisture in microbial cellulose.
- microbial cellulose 400 mL of culture medium (pH 3-4), which was prepared by diluting apple juice with water to 35% (v/v) and adding acetic acid 1% (v/v), was placed in a 1 L Erlenmeyer flask, and inoculated with Acetobacter xylinum, followed by incubation with shaking at 30°C and 150 rpm for 1-3 days.
- the prepared culture as a starter was inoculated to a 1 L beaker containing 400 mL of apple juice diluted solution (pH 3-4) with the concentration of 5% (v/v), followed by stationary culture at 30°C for 5-8 days.
- the apple juice diluted solution was prepared by diluting apple juice to 35% (v/v) with water and adding with acetic acid 1% (v/v) and sugar 10% (v/v).
- the wet sheet was allowed to absorb the treating agent for a burn again and restored into the thickness of 2-6 mm with moisture 40-60%, thus providing a sheet for treating a burn.
- mice Twenty hairless BALB/c mice (Samtako, Inc., Korea) were marked in the back to make 2 cm x 2 cm square. Third-degree burns were induced by applying 100 mM lactate ringer solution to the marked skin. After 30 minutes, ten mice were applied with bio-cellulose sheets prepared in Example 1, while the other ten mice were applied with commercially available gauzes. Bio-cellulose sheets and gauzes were replaced with new ones every day , and the change of skin condition was observed.
- bio-cellulose sheet according to the present invention showed no skin reddishness such as erythema, thus being superior in relieving skin problems without skin irritation.
- a sheet device comprising bio-cellulose herein has a very dense structure and shows superiority in skin adhesion and water retention.
- a sheet device herein When applied to the damaged skin of human or animal, a sheet device herein has been ascertained as effective in rapidly alleviating skin damage, and also as effective in safely relieving skin problem without irritation.
- a skin device herein may be usefully used for the purpose of alleviating skin damage and relieving skin problem.
Abstract
The present invention relates to a sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem. Specifically, when used to treat skin damage due to a wound and a burn, a sheet device according to the present invention may effectively absorb the exudates, contains various water retention agents as well as a wound-treating agent and easily adheres to skin without using other material, thus being usefully usable as a sheet device that may effectively alleviate skin damage while relieving skin problem without skin irritation.
Description
Description
A SHEET DEVICE COMPRISING BIO-CELLULOSE FOR ALLEVIATING SKIN DAMAGE AND RELIEVING SKIN
PROBLEM
Technical Field
[1] The present invention relates to a natural sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem. Specifically, when applied to a wound or a burn in the form of a sheet, a patch or a mask pack, a sheet device herein, which comprises microbial cellulose and optionally further comprises pure or mixed active drug, may effectively absorb the exudates, thus being useful as a sheet device that may effectively alleviate skin damage such as a wound and a burn, etc. and relieve skin problem without skin irritation.
Background Art
[2] For skin care or helping treatment or alleviation of skin damages, the use of a sheet device such as a sheet, a patch and a mask pack has been on the increase instead of cream and lotion. Various sheets, patches and mask packs for skin care is commercially available, and a sheet device useful in delivering skin care activator such as vitamin activator, treatment activator and moisture supplier is also known and used in medical treatment for the transdermal delivery of medicines.
[3] However, these sheets have drawbacks in physical shape of goods and in uncom- fortableness for users. For example, a cosmetic mask pack is prepared by infiltrating face lotion in non-woven fabric, which contains plant cellulose as a main ingredient, or by coating collagen on non-woven fabric. However, the non-woven fabric has a drawback of low water retentive property. Further, some sheet devices easily become damp and sticky because they do not form solid gel structure, thus being difficult to handle and apply to the skin. Other patches also show too strong adhesion during the attachment or detachment, thus giving tight and uncomfortable feeling, and do not make active drug effectively released and penetrated. Moreover, some sheet devices can not be conformed to the curvature of skin due to the dry and non-flexible property.
[4] For the effective treatment of wounds, it is necessary to remove impurities, remains and necrotic tissue without damaging healthy cells. Further, dry wounds should be supplied with certain amount of moisture although too much moisture may soften skin around the wounds. A general treatment of a wound or a burn has been to clean wounds about twice a day using a soft soap, to apply an ointment to the wound or the burn and then to cover the wound or the burn with gauze. However, when exudate is leaked from the wound or the burn, it usually flows out of the gauze due to the low
water absorptive property of the gauze. Use of multi-layers of gauze for overcoming the aforementioned problems causes elevation of the temperature in the wound or the burn, thus promoting inflammation. Further, the continuous use of gauze, which is made of synthetic resins, may irritate the skin. Owing to the limited usage of gauze, there is a need to develop a substitute for gauze using natural material.
[5] Microbial cellulose is a polymer produced through cultivating strains in various bacteria, particularly Acetobacter genus, and obtained in the form of semi-transparent pellicle existing in culture medium under the stationary cultivation [GB patent No. 2131701]. Although it is linked by β-1,4 glucosidic bonds like cellulose, microbial cellulose has significant industrial utility in that the fiber width is about 0.04-0. lμm, i.e. about 150 times smaller than that of cellulose (20-50μm) and that it has three- dimensional network structure.
[6] Therefore, the inventors have exerted extensive efforts to find natural material that
(i) may create humid atmosphere and decrease the dead space in the wounds (Wound Hydration), (ii) may protect the wounds from exterior pollution source and bacteria, and may create and maintain the optimum humid atmosphere for assisting natural recovery, (iii) may manage excess exudates (Exudate Management), and (iv) is safe and non-noxious. As a result, the present inventors perceived that a microbial cellulose gel plate has very similar properties to pulp, while being superior in water-absorptive and water-retentive property owing to the three-dimensional network structure, which is denser than that of pulp. Therefore, the present invention has been completed based on the findings that bio-cellulose may be prepared by post-treating microbial cellulose produced through cultivating strains in Acetobacter genus, while maintaining the original gel phase, followed by compression and removal of moisture, and that thus prepared bio-cellulose may maintain the characteristic three-dimensional network structure and contain a wound-treating agent and various water retention agents, thus being useful as a material for manufacturing a sheet or patch for effectively alleviating skin damage or a mask pack for relieving skin problem. Disclosure of Invention Technical Problem
[7] The present invention aims to provide a sheet device useful in alleviating skin damage due to a burn and a wound and relieving skin problem without irritation. Technical Solution
[8] To serve the aforementioned purpose, the present invention provides a sheet device comprising bio-cellulose.
[9] A sheet device herein may be prepared into a sheet, a patch for treating or alleviating skin damage due to a burn and a mask pack for relieving skin problem.
[10] Bio-cellulose herein may comprise microbial cellulose, an active drug and moisture.
Specifically, bio-cellulose herein may comprise 1-50 wt% of microbial cellulose, 1-10 wt% of an active drug and 40-98 wt% of moisture, preferably 3-10 wt% of microbial cellulose, 1-5 wt% of an active drug and 70-96 wt% of moisture.
[11] An active drug herein may be selected among sulfonamide acetate, sulfamylon, silver sulfadiazine, silvadene, Vaseline and a mixture thereof.
[12] Besides bio-cellulose, an active drug and moisture, a sheet device herein may further comprise a water-retention agent in the amount of 15.0-20.0 wt% relative to the total weight of the sheet device. A water-retention agent herein may be selected among glycerin, propylene glycol, butylene glycol, polyethylene glycol, sorbitol, maltitol, polyhydric alcohol, hyaluronic acid, amino acid, natto gum and sodium lactate. Further, a sheet device may also comprise a growth factor (e.g. TGF-,TGF-, TNF-, PDGF, bFGF, GM-CSF, IL-I, IL-6, IL-8 and fibronectin) to promote the treatment of a wound by accelerating the proliferation and movement of keratinocyte and fibroblast. A combinational secretion of various factors stimulates dermal fibroblast and promotes the generation of collagen, thus creating an atmosphere where the re-epitheliatization of wounds may happen from periwound skin and skin appendages.
[13] To inactivate residual metal ions, a sheet device herein may comprise a sequestering agent (or a chelating agent) such as EDTA (ethylenediamine tetraacetic acid), citric acid and NTA (nitrilotriacetic acid) in the amount of 0.01-0.5 wt% relative to the weight of total weight of the sheet device. A sheet device herein may further comprise an antioxidant such as WHITE TEA, tocopherol, gallic acids, BHT and BHA in the amount of 0.5-1.0 wt% to inhibit the oxidation; a soothing agent such as DPG (dipotassium glycyrrhizate) in the amount of 0.01-0.5 wt%; a solubilizing agent such as POE hydrogenated castor oil and POE oleyl alcohol ether in the amount of 0.01-0.1 wt%; and a saponifying agent such as triethanolamine in the amount of 0.01-0.2wt%. The aforementioned ingredients may be incorporated into the sheet device in combination with deionized water, and the amounts above are relative to the total weight of the sheet device. Advantageous Effects
[14] A sheet device comprising bio-cellulose herein has a very dense structure and shows superiority in skin adhesion and water retention. When applied to the damaged skin of men or animals, a sheet device herein has been ascertained as effective in rapidly alleviating skin damage, and also as effective in safely relieving skin problem without irritation. Thus, a skin device herein may be useful for the purpose of alleviating skin damage and relieving skin problem.
Brief Description of the Drawings
[15] Figure 1 is a photograph, which compares change of the skin condition after applying bio-cellulose sheet of the present invention {series (b)} with that after applying commercially available gauze {series (a)} to a burn-induced hairless mouse.
[16] Figure 2 is a SEM photograph, which compares between cellulose of the present invention {photograph (a)} and plant cellulose {photograph (b)}. Best Mode for Carrying Out the Invention
[17] Bio-cellulose of the present invention may be prepared by adding fructose and moisture in a microbial cellulose as described below.
[18] Specifically, a process for preparing bio-cellulose from a microbial cellulose comprises the steps of:
[19] (a) preparing microbial cellulose in a semi-transparent gel phase by (i) inoculating microbial cellulose producing strain, preferably Acetobacter genus, to microbial cellulose producing culture medium, preferably fruit juice containing acetic acid and sugar; (ii) incubating the strain in a shaking or air lift type incubator, thus providing the dispersion of particle-shaped or pellet-shaped microbial cellulose; and (iii) inoculating the culture to microbial cellulose producing medium using the culture per se as a starter and performing stationary cultivation;
[20] (b) preparing a wet sheet with the thickness of about 0.2-1 mm, preferably 0.,4-0.8 mm and the moisture of 40-90%, preferably 50-80% by (i) immersing the semi- transparent microbial cellulose in water, and washing and heating the microbial cellulose to remove media ingredients and fungus bodies inside, thus providing impurity-free gel-phased microbial cellulose; and (ii) compressing the gel-phased microbial cellulose in an air or oil compressor using sponge or filter cloth;
[21] (c) preparing bio-cellulose wet sheet, which is restored into the thickness of 0.5-10 mm, preferably 1-8 mm, by immersing the wet sheet in the pre-manufactured 10-80% solution of active drug such as sulfonamide acetate, sulfamylon, silver sulfadiazine, silvadene or Vaseline for 0.1-10 day, preferably 1-3 days, to allow the wet sheet to contain the active drug in the concentration of 1-10 wt%, preferably 1-5 wt%.
[22] The present invention provides a thus prepared sheet device comprising bio- cellulose as an active ingredient, which is useful in alleviating skin damage due to a wound and a burn and relieving skin problem. The followings have been ascertained with regard to the sheet device: (i) it has a very dense structure by SEM analysis, (ii) it shows superiority in skin adhesion and water retention, (iii) when applied to the damaged skin of human or animal, it is effective in rapidly alleviating skin damage and safely relieving skin problem without irritation. The present invention has been completed based on the aforementioned advantages of a sheet device herein. Mode for the Invention
[23] The present invention is described more specifically by the following Examples and
Experimental Examples. Examples and Experimental Examples herein are meant only to illustrate the present invention, but in no way to limit the scope of the claimed invention.
[24] Example 1: Preparation of bio-cellulose sheet
[25] 1-1. Preparation of microbial cellulose
[26] Bio-cellulose of the present invention may be prepared by adding fructose and moisture in microbial cellulose. For the manufacture of microbial cellulose, 400 mL of culture medium (pH 3-4), which was prepared by diluting apple juice with water to 35% (v/v) and adding acetic acid 1% (v/v), was placed in a 1 L Erlenmeyer flask, and inoculated with Acetobacter xylinum, followed by incubation with shaking at 30°C and 150 rpm for 1-3 days. Then, the prepared culture as a starter was inoculated to a 1 L beaker containing 400 mL of apple juice diluted solution (pH 3-4) with the concentration of 5% (v/v), followed by stationary culture at 30°C for 5-8 days. The apple juice diluted solution was prepared by diluting apple juice to 35% (v/v) with water and adding with acetic acid 1% (v/v) and sugar 10% (v/v).
[27] 1-2. Preparation of wet sheet
[28] Thus prepared microbial cellulose with thickness of 5-8 mm in a semi-transparent phase contains media ingredients and fungus bodies. To remove the impurities, the microbial cellulose was immersed in water for 1-2 days, washed with pure water once or twice and heated at 100°C for 20-60 minutes. The impurity-free microbial cellulose in a gel phase was compressed in an air compressor into a thickness of 0.4-0.8mm using sponge, thus providing a wet sheet of microbial cellulose with a moisture content of 50-80%.
[29] 1-3. Preparation of wet sheet comprising active drug
[30] Thus prepared wet sheet was immersed in 200 mL of a treating agent for a burn,
Vaseline 50% (w/v), for 1-2 days, which was prepared in advance. The wet sheet was allowed to absorb the treating agent for a burn again and restored into the thickness of 2-6 mm with moisture 40-60%, thus providing a sheet for treating a burn.
[31] Referential Example 1: Structure Evaluation cellulose sheet
[32] After dried sufficiently, a cellulose sheet was coated with metal according to a sputter coating procedure [Bell PB Jr, Lindroth M, Fredriksson BA, J. Electron Microsc Tech., Nov:7 (3). ppl49-159, 1987]. SEM photograph was taken by using a scan electron microscope (Hitachi S-2350, Japan). As shown in Figure 2, the prepared sheet was observed to have fine-shaped fibers even when enlarged 20,000 times, thus ascertaining fine fibrous structure and superior skin adhesion of the cellulose sheet along with superior water-retentive effect.
[33] Experimental Example 1: Evaluation of efficacy of bio-cellulose sheet in al-
leviating skin damage
[34] The efficacy of bio-cellulose sheet in alleviating skin damage was evaluated as described below.
[35] Twenty hairless BALB/c mice (Samtako, Inc., Korea) were marked in the back to make 2 cm x 2 cm square. Third-degree burns were induced by applying 100 mM lactate ringer solution to the marked skin. After 30 minutes, ten mice were applied with bio-cellulose sheets prepared in Example 1, while the other ten mice were applied with commercially available gauzes. Bio-cellulose sheets and gauzes were replaced with new ones every day , and the change of skin condition was observed.
[36] As shown in Figure 1, the group applied with bio-cellulose sheets herein {series
(b)} were more rapid in skin damage relief than the group applied with gauzes {series (a)}. Crusts were formed after 3 days and 1 day in the gauze-applied group and the bio- cellulose sheet-applied group, respectively. Thus, it was ascertained that bio-cellulose sheet has an efficacy of alleviating skin damage.
[37] Experimental Example 2: Evaluation of efficacy of bio-cellulose sheet in relieving skin problem
[38] To evaluate the efficacy of bio-cellulose sheet herein in relieving skin problem, skin patch test was performed as described in a publication (Notice issued by Korea Food & Drug Administration No. 1999-61; Preclinical safety evaluation of biotechnology- derived pharmaceuticals Article 9; Local irritation test).
[39] Following inducing burns on New Zealand white rabbits (Korean Laboratory
Animal Center, Korea), the change of skin condition was evaluated at the predetermined interval after the application, and scored based on the evaluation standards presented in Table 1 (Draize et al., J. Pharmacol. Exp. Then, 82» pp377-390, 1944). As shown in Table 2, bio-cellulose sheet according to the present invention showed no skin reddishness such as erythema, thus being superior in relieving skin problems without skin irritation.
[40] Table 1
[41] Table 2
Industrial Applicability
[42] A sheet device comprising bio-cellulose herein has a very dense structure and shows superiority in skin adhesion and water retention. When applied to the damaged skin of human or animal, a sheet device herein has been ascertained as effective in rapidly alleviating skin damage, and also as effective in safely relieving skin problem without irritation. Thus, a skin device herein may be usefully used for the purpose of alleviating skin damage and relieving skin problem.
[43]
Claims
[1] A sheet device for alleviating skin damage and relieving skin problem, comprising bio-cellulose.
[2] The sheet device of claim 1, wherein the sheet device is in the form selected from the group consisting of a sheet, a patch and a mask pack.
[3] The sheet device of claim 1, further comprising an active drug and moisture.
[4] The sheet device of claim 3, wherein the active drug is at least one selected from the group consisting of sulfonamide acetate, sulfamylon, silver sulfadiazine, silvadene and Vaseline. [5] The sheet device of claim 1, wherein the bio-cellulose comprises 1-50 wt% of a microbial cellulose, 1-10 wt% of a active drug and 40-98 wt% of moisture.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2006-0011382 | 2006-02-07 | ||
KR20060011382 | 2006-02-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007091801A1 true WO2007091801A1 (en) | 2007-08-16 |
Family
ID=38345365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2007/000544 WO2007091801A1 (en) | 2006-02-07 | 2007-02-01 | A sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW200803924A (en) |
WO (1) | WO2007091801A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2916948A1 (en) * | 2007-06-06 | 2008-12-12 | Oreal | Article or device for perfuming human body or for progressive perfume diffusion in an atmosphere, comprises a substrate comprising a pure biocellulose, a fixation unit comprising an adhesive, and a support unit |
EP2011470A1 (en) * | 2007-07-02 | 2009-01-07 | L'Oreal | Assembly including a substrate comprising biocellulose and a powdery cosmetic composition to be placed in contact with the substrate |
US7832857B2 (en) | 2008-08-18 | 2010-11-16 | Levinson Dennis J | Microbial cellulose contact lens |
KR101109034B1 (en) | 2009-06-17 | 2012-01-31 | 김홍남 | Method for mass production of microbial cellulose and method for mask pack using there of |
WO2012131623A2 (en) | 2011-03-31 | 2012-10-04 | L'oreal | Fractional cosmetic treatment process using a laser or microneedles |
WO2013094077A1 (en) * | 2011-12-19 | 2013-06-27 | L'oreal | Cosmetic bio-cellulose sheet for lips |
WO2017089005A1 (en) | 2015-11-25 | 2017-06-01 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103170002A (en) * | 2011-12-21 | 2013-06-26 | 佳美食品工业股份有限公司 | Biological fiber dressing as well as preparation method and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588400A (en) * | 1982-12-16 | 1986-05-13 | Johnson & Johnson Products, Inc. | Liquid loaded pad for medical applications |
US4655758A (en) * | 1982-12-16 | 1987-04-07 | Johnson & Johnson Products, Inc. | Microbial polysaccharide articles and methods of production |
US20040142019A1 (en) * | 2003-01-16 | 2004-07-22 | Xylos Corporation | Microbial-derived cellulose amorphous hydrogel wound dressing |
WO2005003366A1 (en) * | 2003-07-03 | 2005-01-13 | Politechnika Lodzka | A method for the production of bacterial cellulose |
WO2006006167A2 (en) * | 2004-07-13 | 2006-01-19 | Mediwound Ltd. | Compositions and methods for dermatological wound healing |
-
2007
- 2007-02-01 WO PCT/KR2007/000544 patent/WO2007091801A1/en active Application Filing
- 2007-02-06 TW TW096104262A patent/TW200803924A/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588400A (en) * | 1982-12-16 | 1986-05-13 | Johnson & Johnson Products, Inc. | Liquid loaded pad for medical applications |
US4655758A (en) * | 1982-12-16 | 1987-04-07 | Johnson & Johnson Products, Inc. | Microbial polysaccharide articles and methods of production |
US20040142019A1 (en) * | 2003-01-16 | 2004-07-22 | Xylos Corporation | Microbial-derived cellulose amorphous hydrogel wound dressing |
WO2005003366A1 (en) * | 2003-07-03 | 2005-01-13 | Politechnika Lodzka | A method for the production of bacterial cellulose |
WO2006006167A2 (en) * | 2004-07-13 | 2006-01-19 | Mediwound Ltd. | Compositions and methods for dermatological wound healing |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2916948A1 (en) * | 2007-06-06 | 2008-12-12 | Oreal | Article or device for perfuming human body or for progressive perfume diffusion in an atmosphere, comprises a substrate comprising a pure biocellulose, a fixation unit comprising an adhesive, and a support unit |
EP2011470A1 (en) * | 2007-07-02 | 2009-01-07 | L'Oreal | Assembly including a substrate comprising biocellulose and a powdery cosmetic composition to be placed in contact with the substrate |
FR2918275A1 (en) * | 2007-07-02 | 2009-01-09 | Oreal | ASSEMBLY COMPRISING A SUBSTRATE HAVING BIOCELLULOSE AND A COSMETIC COMPOSITION PULVERULENT TO CONTACT WITH THE SUBSTRATE |
US7832857B2 (en) | 2008-08-18 | 2010-11-16 | Levinson Dennis J | Microbial cellulose contact lens |
KR101109034B1 (en) | 2009-06-17 | 2012-01-31 | 김홍남 | Method for mass production of microbial cellulose and method for mask pack using there of |
WO2012131623A2 (en) | 2011-03-31 | 2012-10-04 | L'oreal | Fractional cosmetic treatment process using a laser or microneedles |
FR2973237A1 (en) * | 2011-03-31 | 2012-10-05 | Oreal | FRACTIONAL COSMETIC TREATMENT PROCESS USING LASER OR MICRO-NEEDLES |
WO2012131623A3 (en) * | 2011-03-31 | 2013-02-28 | L'oreal | Fractional cosmetic treatment process using a laser or microneedles |
WO2013094077A1 (en) * | 2011-12-19 | 2013-06-27 | L'oreal | Cosmetic bio-cellulose sheet for lips |
WO2017089005A1 (en) | 2015-11-25 | 2017-06-01 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
US10736823B2 (en) | 2015-11-25 | 2020-08-11 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
EP3900699A1 (en) | 2015-11-25 | 2021-10-27 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
US11529433B2 (en) | 2015-11-25 | 2022-12-20 | JeNaCell GmbH | Biotechnologically-produced cellulose-containing article for dermatological use |
Also Published As
Publication number | Publication date |
---|---|
TW200803924A (en) | 2008-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007091801A1 (en) | A sheet device comprising bio-cellulose for alleviating skin damage and relieving skin problem | |
KR100676937B1 (en) | Water soluble film for skin care and wound repair and method for their preparation | |
TWI398275B (en) | Skin wound dressing and manufacturing method thereof | |
TW201142033A (en) | Bacterial cellulose film, and use thereof | |
TW201236702A (en) | Dressing comprising active components of centella asiatica and use of the same | |
CN103341216B (en) | Scar-removing repairing material and preparation method thereof | |
JP7382373B2 (en) | Cellulose-containing articles for skin | |
CN103340722A (en) | Sanitary towel good in water-absorbing performance | |
CN100540065C (en) | The manufacture method of cross-linking radiation holey human acellular amniotic membrane aerogel dressing | |
CN103159967A (en) | Preparation method of collagen-based sponge wound dressing with self-anti-inflammatory function | |
CN111135154B (en) | Anti-aging bacterial cellulose membrane and preparation method thereof | |
CN113061265A (en) | Polysaccharide hydrogel, preparation method and application thereof | |
CN107441479B (en) | Marine active peptide/chitin burn ointment for treating scald and preparation method thereof | |
CN101019793A (en) | Interactive medical wet dressing and its prepn and application | |
CN109966540B (en) | Preparation method and application of nano chitin composite calcium alginate medical dressing | |
CN105193686B (en) | A kind of Feminine care solution and preparation method thereof | |
JP2021532283A (en) | Biocellulose sheet and its manufacturing method | |
RU2370270C1 (en) | Composition for wound treatment | |
Imran et al. | Tualang honey hydrogel in the treatment of split-skin graft donor sites | |
CN111870590B (en) | Liquid acne-removing patch and preparation method thereof | |
CN111714404B (en) | Acne-removing composition and preparation method and application thereof | |
CN112023110B (en) | Active antibacterial dressing based on bamboo fungus egg extract | |
CN113842492A (en) | Hydrogel/non-woven material composite dressing loaded with centella asiatica extract | |
CN103893816A (en) | Method for preparing composite amniotic extracellular matrix dressing of bacterial cellulose containing plant ingredients | |
CN102405293A (en) | Membrane of biological fibers, and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07708695 Country of ref document: EP Kind code of ref document: A1 |